Načítá se...
Clinical outcomes of low-dose-rate brachytherapy based radiotherapy for intermediate risk prostate cancer
PURPOSE: To monitor the outcomes for intermediate-risk prostate cancer patients treated with biologically effective dose (BED) ≥ 200 Gy radiotherapy using low-dose-rate (LDR) brachytherapy. MATERIAL AND METHODS: Between 2005 and 2016, a total of 397 patients with intermediate-risk prostate cancer we...
Uloženo v:
| Vydáno v: | J Contemp Brachytherapy |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Termedia Publishing House
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7073334/ https://ncbi.nlm.nih.gov/pubmed/32190064 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/jcb.2020.92405 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|